Maria-Luisa Maccecchini
Maria-Luisa Maccecchini founded Annovis Bio, Inc., Message Pharmaceuticals, Inc. and Annovis, Inc. Currently, Dr. Maccecchini occupies the position of President, Chief Executive Officer & Director at Annovis Bio, Inc. Dr. Maccecchini is also on the board of Treventis Corp., Lantern Pharma, Inc. and Translational Development Acquisition Corp.
She previously was Chief Executive Officer for Message Pharmaceuticals, Inc., General Manager at Bachem Bioscience, Inc., Member of Robin Hood Ventures, Chief Executive Officer at Annovis, Inc., Head-Molecular Biology at Mallinckrodt, Inc.(Old), Director & Partner at Mid-Atlantic Angel Group and Head-Molecular Biology at Mallinckrodt LLC.
Maria-Luisa Maccecchini received a doctorate from The Rockefeller University.
Transactions
| 01/14/2022 | 32,959 | Derivative/Non-derivative trans. at $0.14 per share. | 4,614 |
| 12/20/2021 | 20,000 | Gift at $0 per share. | 0 |
| 10/11/2021 | 18,000 | Acquisition at $27.61 per share. | 496,980 |
| 07/01/2021 | 1,000 | Gift at $0 per share. | 0 |
| 07/01/2021 | 1,000 | Gift at $0 per share. | 0 |
| 07/15/2020 | 10,000 | Gift at $0 per share. | 0 |
| 04/27/2020 | 10,000 | Gift at $0 per share. | 0 |
| 01/31/2020 | 762,896 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/31/2020 | 7,937 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/31/2020 | 1,600 | Acquisition at $6 per share. | 9,600 |
